Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Hu, Peizhen ^a,b   Chu, Gina C Y ^a   Zhu, Guodong ^c   Yang, Hua ^d   Luthringer, Daniel ^a   Prins, Gail ^e   Habib, Fouad ^f   Wang, Yuzhuo ^g   Wang, Ruoxiang ^a   Chung, Leland W K ^a   Zhau, Haiyen E ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN MCL 1; SCATTER FACTOR RECEPTOR; QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CASTRATION RESISTANT PROSTATE CANCER; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MULTIPLEXED QUANTUM DOT LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; ORCHIECTOMY; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; STAINING; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MOLECULAR TARGETED THERAPY; ORCHIECTOMY; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; QUANTUM DOTS; RANK LIGAND; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STAINING AND LABELING; TRANSFECTION; TREATMENT OUTCOME;

EID: 83755185942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028670     Document Type: Article

References (33)

1. Hu M, Yan J, He Y, Lu H, Weng L, et al. (2010) Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip. ACS Nano 4: 488-494.
2. Leung K, (2004) Quantum dot 800-prostate-specific membrane antigen antibody J591.
3. Shi C, Zhou G, Zhu Y, Su Y, Cheng T, et al. (2008) Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells. Eur J Histochem 52: 127-134.
4. Wagner MK, Li F, Li J, Li XF, Le XC, (2010) Use of quantum dots in the development of assays for cancer biomarkers. Anal Bioanal Chem 397: 3213-3224.
5. Sweeney E, Ward TH, Gray N, Womack C, Jayson G, et al. (2008) Quantitative multiplexed quantum dot immunohistochemistry. Biochem Biophys Res Commun 374: 181-186.
6. Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, et al. (2007) Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc 2: 1152-1165.
7. Li R, Dai H, Wheeler TM, Sayeeduddin M, Scardino PT, et al. (2009) Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology. Clin Cancer Res 15: 3568-3573.
8. Kong XL, Qi H, Zhou HX, Ren LL, Deng CY, et al. (2010) A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen. Clin Chem Lab Med 48: 279-283.
9. Bailey VJ, Puleo CM, Ho YP, Yeh HC, Wang TH, (2009) Quantum dots in molecular detection of disease. Conf Proc IEEE Eng Med Biol Soc 2009: 4089-4092.
10. Liang RQ, Li W, Li Y, Tan CY, Li JX, et al. (2005) An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucleic Acids Res 33: e17.
11. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, et al. (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103 Jul 101;144(102).
12. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54: 2577-2581.
13. van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, et al. (2003) Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 162: 1529-1537.
14. Chung LW, Li W, Gleave ME, Hsieh JT, Wu HC, et al. (1992) Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl 16H pp. 99-105.
15. Zhang S, Zhau HE, Osunkoya AO, Iqbal S, Yang X, et al. (2010) Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 9: 9.
16. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, et al. (1995) c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154: 293-298.
17. Torres KE, Zhu QS, Bill K, Lopez G, Ghadimi MP, et al. (2011) Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors. Clin Cancer Res 17: 3943-3955.
18. Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, et al. (2005) C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. Int J Cancer 113: 678-682.
19. Zhou AX, Toylu A, Nallapalli RK, Nilsson G, Atabey N, et al. (2011) Filamin a mediates HGF/c-MET signaling in tumor cell migration. Int J Cancer 128: 839-846.
20. Zhang Y, Guessous F, Kofman A, Schiff D, Abounader R, (2010) XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC. IDrugs 13: 112-121.
21. Smith DC, Soira A, De Greve J, Hart L, Holbrecht S, et al. (2010) Phase 2 study of XL184 in a cohort of patients with castration resistant prostate cancer. EORTC pp. 406a.
22. Tobar N, Villar V, Santibanez JF, (2010) ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340: 195-202.
23. Chu GCY, Wang RX, Zhau HE, Xu F, Chung LWK, (2010) Autocrine and Paracrine Cell Signaling Mediated by RANKL-RANK Interaction Promotes Epithelial to Mesenchymal Transition of Human Prostate Cancer Cells. Society For Basic Urologic Research.
24. Prins GS, Birch L, Greene GL, (1991) Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129: 3187-3199.
25. Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, et al. (2010) Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 17: 535-546.
26. Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, et al. (2008) Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clin Exp Metastasis 25: 601-610.
27. Ghazani AA, Lee JA, Klostranec J, Xiang Q, Dacosta RS, et al. (2006) High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett 6: 2881-2886.
28. Liu J, Lau SK, Varma VA, Moffitt RA, Caldwell M, et al. (2010) Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano 4: 2755-2765.
29. Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, et al. (2011) Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Res 71: 5204-5213.
30. Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, et al. (2009) Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Cell Mol Med 13: 2673-2683.
31. Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, et al. (2008) Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 18: 858-870.
32. Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, et al. (2011) EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene.
33. Yurube T, Takada T, Hirata H, Kakutani K, Maeno K, et al. (2011) Modified house-keeping gene expression in a rat tail compression loading-induced disc degeneration model. J Orthop Res 29: 1284-1290.